Accession | ARO:3007541 |
Definition | Cyclomarin A was found to be bacteriocidal against bacteria replicating in culture broth and in human-derived macrophages and a series of multidrug resistant clinical isolates. It was identified as a potent antitubercular compound in a natural product whole cell screen. Importantly it kills both growing and dormant, non-replicating mycobacteria. |
SMILES | N/A |
PubChem | 10772429 |
Drug Class | cyclomarin antibiotics |
Classification | 2 ontology terms | Show |
Parent Term(s) | 1 ontology terms | Show + cyclomarin antibiotics [Drug Class] |
Publications | Samukawa N, et al. 2022. Microbiology (Reading) 168(12): An efficient CRISPR interference-based prediction method for synergistic/additive effects of novel combinations of anti-tuberculosis drugs. (PMID 36748577) Barbie P, et al. 2016. Org Biomol Chem 14(25):6036-54 Total synthesis of cyclomarins A, C and D, marine cyclic peptides with interesting anti-tuberculosis and anti-malaria activities. (PMID 27241518) |
Curator | Description | Most Recent Edit |
---|